BioCentury
ARTICLE | Financial News

Labopharm raises $88 million

April 29, 2006 12:04 AM UTC

Labopharm (TSX:DDS; DDSS) raised US$88 million through the sale of 11 million shares at US$8 in a bumped-up follow-on underwritten by Merrill Lynch; Banc of America Securities; Canaccord; Leerink; Orion Securities; Dundee; and Westwind Partners. In conjunction with the deal, the company listed its shares on NASDAQ. DDS proposed to sell 10 million shares last week. ...